Tower Research Capital (TRC)’s Eterna Therapeutics ERNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-333
| Closed | -$5.24K | – | 5766 |
|
|
2024
Q3 | $5.24K | Sell |
333
-12
| -3% | -$189 | ﹤0.01% | 4304 |
|
|
2024
Q2 | $9.47K | Buy |
345
+73
| +27% | +$2K | ﹤0.01% | 4246 |
|
|
2024
Q1 | $9.8K | Sell |
272
-22
| -7% | -$793 | ﹤0.01% | 3788 |
|
|
2023
Q4 | $7.91K | Sell |
294
-13
| -4% | -$350 | ﹤0.01% | 4560 |
|
|
2023
Q3 | $10K | Sell |
307
-28
| -8% | -$915 | ﹤0.01% | 4155 |
|
|
2023
Q2 | $11.4K | Buy |
335
+332
| +11,067% | +$11.3K | ﹤0.01% | 3959 |
|
|
2023
Q1 | $0 | Sell |
3
-11
| -79% | – | ﹤0.01% | 5919 |
|
|
2022
Q4 | $0 | Sell |
14
-120
| -90% | – | ﹤0.01% | 6001 |
|
|
2022
Q3 | $10K | Buy |
134
+68
| +103% | +$5.08K | ﹤0.01% | 4527 |
|
|
2022
Q2 | $10K | Buy |
66
+35
| +113% | +$5.3K | ﹤0.01% | 4441 |
|
|
2022
Q1 | $19K | Buy |
31
+22
| +244% | +$13.5K | ﹤0.01% | 3573 |
|
|
2021
Q4 | $12K | Buy |
9
+5
| +125% | +$6.67K | ﹤0.01% | 4271 |
|
|
2021
Q3 | $12K | Buy |
4
+1
| +33% | +$3K | ﹤0.01% | 4140 |
|
|
2021
Q2 | $19K | Sell |
3
-3
| -50% | -$19K | ﹤0.01% | 3927 |
|
|
2021
Q1 | $6K | Hold |
6
| – | – | ﹤0.01% | 4589 |
|
|
2020
Q4 | $7K | Buy |
+6
| New | +$7K | ﹤0.01% | 4485 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 3941 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 3890 |
|
|
2016
Q4 | – | Sell |
-2
| Closed | -$7K | – | 3959 |
|
|
2016
Q3 | $7K | Buy |
+2
| New | +$7K | ﹤0.01% | 2317 |
|
|
2016
Q1 | – | Hold |
0
| – | -$1K | – | 4325 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 4060 |
|